IVAX Diagnostics, Inc. (NYSE Amex:IVD) today reported that, in light of the unusual market activity in its stock, the NYSE Amex contacted IVAX Diagnostics in accordance with the NYSE Amex’s usual practice. IVAX Diagnostics confirmed that its policy is not to comment on unusual market activity.

About IVAX Diagnostics, Inc.

IVAX Diagnostics, Inc. (www.ivaxdiagnostics.com), headquartered in Miami, Florida, is a fully integrated in vitro diagnostics company that develops, manufactures and distributes in the United States and internationally, proprietary diagnostic reagents, test kits and instrumentation, primarily for autoimmune and infectious diseases, through its three subsidiaries: Diamedix Corporation (U.S.), Delta Biologicals S.r.l. (Europe), and ImmunoVision, Inc. (U.S.).

Ivax Diagnostics (AMEX:IVD)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Ivax Diagnostics Charts.
Ivax Diagnostics (AMEX:IVD)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Ivax Diagnostics Charts.